JPH0196189A - Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance - Google Patents
Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substanceInfo
- Publication number
- JPH0196189A JPH0196189A JP25386087A JP25386087A JPH0196189A JP H0196189 A JPH0196189 A JP H0196189A JP 25386087 A JP25386087 A JP 25386087A JP 25386087 A JP25386087 A JP 25386087A JP H0196189 A JPH0196189 A JP H0196189A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- spectrum
- color
- methanol
- chloroform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 106
- QAXIGMXDHAMYPV-UHFFFAOYSA-N methyl 1,6,8,14a-tetrahydroxy-11-[(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)amino]-6a-methoxy-3-methyl-7,9,12,14-tetraoxo-5,6-dihydrobenzo[a]tetracene-2-carboxylate Chemical compound COC1C(O)C(OC)C(C)OC1NC(C(C1=C2)=O)=CC(=O)C1=C(O)C1=C2C(=O)C2(O)C3=C(O)C(C(=O)OC)=C(C)C=C3CC(O)C2(OC)C1=O QAXIGMXDHAMYPV-UHFFFAOYSA-N 0.000 title claims abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 67
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 42
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 33
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 28
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 230000002378 acidificating effect Effects 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 238000001819 mass spectrum Methods 0.000 claims abstract description 11
- 238000002844 melting Methods 0.000 claims abstract description 11
- 230000008018 melting Effects 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 238000000921 elemental analysis Methods 0.000 claims abstract description 9
- 238000000434 field desorption mass spectrometry Methods 0.000 claims abstract description 9
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 22
- HIZYZNCPKSMSJK-UHFFFAOYSA-N methyl 1,8,14a-trihydroxy-11-[(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)amino]-6a-methoxy-3-methyl-7,9,12,14-tetraoxo-5,6-dihydrobenzo[a]tetracene-2-carboxylate Chemical compound COC1C(O)C(OC)C(C)OC1NC(C(C1=C2)=O)=CC(=O)C1=C(O)C1=C2C(=O)C2(O)C3=C(O)C(C(=O)OC)=C(C)C=C3CCC2(OC)C1=O HIZYZNCPKSMSJK-UHFFFAOYSA-N 0.000 claims description 21
- 239000000741 silica gel Substances 0.000 claims description 21
- 229910002027 silica gel Inorganic materials 0.000 claims description 21
- 238000001228 spectrum Methods 0.000 claims description 17
- 238000004809 thin layer chromatography Methods 0.000 claims description 14
- 230000003115 biocidal effect Effects 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 230000007935 neutral effect Effects 0.000 claims description 9
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 claims description 8
- DOPAQDOSLKBONQ-DDHLINGLSA-N methyl (6r,6as,14ar)-11-amino-1,6,8,14a-tetrahydroxy-6a-methoxy-3-methyl-7,9,12,14-tetraoxo-5,6-dihydrobenzo[a]tetracene-2-carboxylate Chemical compound O=C1C=C(N)C(=O)C2=C1C(O)=C1C(=O)[C@]3(OC)[C@H](O)CC4=CC(C)=C(C(=O)OC)C(O)=C4[C@]3(O)C(=O)C1=C2 DOPAQDOSLKBONQ-DDHLINGLSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 abstract description 8
- 239000003242 anti bacterial agent Substances 0.000 abstract description 5
- 241000187747 Streptomyces Species 0.000 abstract description 3
- 241000187180 Streptomyces sp. Species 0.000 abstract description 3
- VLAPMBHFAWRUQP-UHFFFAOYSA-L molybdic acid Chemical compound O[Mo](O)(=O)=O VLAPMBHFAWRUQP-UHFFFAOYSA-L 0.000 abstract description 3
- 241000192125 Firmicutes Species 0.000 abstract 1
- 239000012445 acidic reagent Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 33
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 24
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 18
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 239000012925 reference material Substances 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- GRONZTPUWOOUFQ-UHFFFAOYSA-M sodium;methanol;hydroxide Chemical compound [OH-].[Na+].OC GRONZTPUWOOUFQ-UHFFFAOYSA-M 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000204031 Mycoplasma Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- -1 D- Mannyl Chemical compound 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は新規抗生物質SF2446八2物質、SF24
46八3物質、SF2446B1物質、SF2446B
2物質及びSF2446B3物質に関するものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention is directed to novel antibiotics SF244682, SF24
4683 substances, SF2446B1 substance, SF2446B
2 substance and SF2446B3 substance.
従来の技術及び発明が解決しようとする問題点従来、数
多くの抗生物質が発明9発見され9人体用医薬品、動物
用医薬品、農薬等の分野で実用化されている。しカルな
がら、まだ有効な物質が見出されていないため解決され
ていない医療或いは産業の分野が数多く残されている。BACKGROUND OF THE INVENTION Conventional techniques and problems to be solved by the invention In the past, many antibiotics have been invented and discovered, and put into practical use in the fields of pharmaceuticals for humans, pharmaceuticals for animals, agricultural chemicals, and the like. However, there are still many medical and industrial fields that remain unsolved because no effective substances have been found.
例えば、−般細菌及びマイコプラズマにより発症する感
染症は単独感染のほか池の細菌と混合感染する極めて厄
介な病気であり、この分野では強力でしかも広範囲な抗
菌活性と抗マイコプラズマ活性を持つ新規な抗生物質を
提供することが常に要望されている。 本発明者らは以
上のような点に着目し、新規な抗生物質を提供するとと
もに、その製造法を確立することによってこれを解決し
ようとするものである。For example, - Infectious diseases caused by common bacteria and mycoplasma are extremely troublesome diseases that can occur not only alone but also in combination with pond bacteria. There is always a need to provide material. The present inventors have focused on the above-mentioned points, and aim to solve the problems by providing a new antibiotic and establishing a method for producing the same.
問題点を解決するための手段
本発明者らは、先にストレプトマイセス属に属する特定
の菌株を培養することにより、各種細菌及びマイコプラ
ズマに対して強い発育阻止作用を有する物質が培養液中
に生産、蓄積されることを見出し、その有効物質を採取
することに成功し、SF2446物質と命名した[特願
昭6l−311156(昭和61年12月19日出願)
1゜
本発明者らはこれと同一菌株の培養液中に池の新規な有
効物質を見付けSF2446A2物質、SF2446A
3物質、SF2446B1物質及びSF244611!
2物質と命名した。Means for Solving the Problems The present inventors first cultivated a specific strain belonging to the genus Streptomyces, thereby creating a substance in the culture solution that has a strong growth-inhibiting effect against various bacteria and mycoplasma. They discovered that it was produced and accumulated, and succeeded in collecting its effective substance, naming it substance SF2446 [Patent Application 1986-311156 (filed on December 19, 1986)
1゜The present inventors found a new effective substance in the culture solution of the same strain, SF2446A2 substance, SF2446A
3 substances, SF2446B1 substance and SF244611!
Two substances were named.
またSF2446B1物質又はSF244611i2物
質を酸で処理することにより新規な抗生物質を得、これ
をSF2446B3物質と命名した。In addition, a new antibiotic was obtained by treating the SF2446B1 substance or the SF244611i2 substance with an acid, and this was named the SF2446B3 substance.
これらの本発明物質は下記の理化学的性状を有する。These substances of the present invention have the following physical and chemical properties.
[1]SF2446A2物質
(1)色及び形状: 赤褐色粉末
(2)元素分析値:C58,10%、 )I 5,26
%。[1] SF2446A2 substance (1) Color and shape: Reddish brown powder (2) Elemental analysis value: C58, 10%, ) I 5,26
%.
N 1.90%
(3)分子式 :C34H35NO15(4)マスス
ペクトル(FD−MS) : m/z 697 (M
+)(5)融点 : 180−184℃ (分解
)(6)紫外部及び可視部吸収スペクトル(第1図)λ
max nm (E!ffl、)
[MeOtll : 216 (648)、22Ss
h (494)−251(448)、270sh (3
70)。N 1.90% (3) Molecular formula: C34H35NO15 (4) Mass spectrum (FD-MS): m/z 697 (M
+) (5) Melting point: 180-184℃ (decomposition) (6) Ultraviolet and visible absorption spectra (Figure 1) λ
max nm (E!ffl,) [MeOtll: 216 (648), 22Ss
h (494)-251(448), 270sh (3
70).
300sh (211)、 417 (85)。300sh (211), 417 (85).
[0,1811CI−MeOH] : 217 (6
10)、 227sh (475)、。[0,1811CI-MeOH]: 217 (6
10), 227sh (475),.
250 (451)、 270sh (376)。250 (451), 270sh (376).
300sh (211)、 415 (92)。300sh (211), 415 (92).
[0,IN NaOH−Me111] : 213
(1210)、 240sh (535)。[0,IN NaOH-Me111]: 213
(1210), 240sh (535).
300sh (212)、 574 (123)(7)
赤外部吸収スペクトル(第6図)(KBr am ’)
: 3430.2920.2820.1720゜168
0.1650.1B15.1590゜1560、151
0.1460.1410゜1360、1300.126
0.1210゜1160、1110.1095.105
0゜955、940.890.870.810゜(8)
1HNMRスヘ9 )ル(400MHz、 CDC
l5)(第11図)
δ(Ilpm) : 1.22 (3L d)+ 2
.32 (3L br S)+3.03 (LH,br
d)、3.14 (IH,dd)。300sh (212), 574 (123) (7)
Infrared absorption spectrum (Figure 6) (KBram')
: 3430.2920.2820.1720°168
0.1650.1B15.1590°1560, 151
0.1460.1410°1360, 1300.126
0.1210°1160, 1110.1095.105
0°955, 940.890.870.810° (8)
1HNMR spectrum (400MHz, CDC)
l5) (Figure 11) δ (Ilpm): 1.22 (3L d) + 2
.. 32 (3L br S)+3.03 (LH, br
d), 3.14 (IH, dd).
3゜35 (IH,br d)、3.42 (3H,5
)−3,48(3H,S)、 3.54 (IH,dd
)。3゜35 (IH,br d), 3.42 (3H,5
)-3,48(3H,S), 3.54(IH,dd
).
3.57 (38,s)、3.60 (38,s)。3.57 (38,s), 3.60 (38,s).
’ 3.60 (IH,dc+)、3.87 (I
H,dd)。' 3.60 (IH, dc+), 3.87 (I
H, dd).
4.39 (1肌br ddd)。4.39 (1 skin br ddd).
4.92 (IH,d)、 4.97 (IH,dd)
。4.92 (IH, d), 4.97 (IH, dd)
.
5.25 (1)1. dd)、 5.96 (1)1
. br s)。5.25 (1)1. dd), 5.96 (1)1
.. brs).
6.19 (IH,s)、 6.49 (IH,br
s)。6.19 (IH, s), 6.49 (IH, br
s).
6.84 (IH,d)、 8.47 (IH,s)。6.84 (IH, d), 8.47 (IH, s).
11.85 (ill、 s)、14.26 (IH,
5(9) 13CNMRスペクトル(100Mtlz
、 CDCl5)(第16図)
δ(ppω) : 196,5 !3t 190,2
St 188.8 s。11.85 (ill, s), 14.26 (IH,
5(9) 13CNMR spectrum (100 Mtlz
, CDCl5) (Fig. 16) δ(ppω): 196,5! 3t 190,2
St 188.8 s.
179.5 s、 171.9 s、 162,5 s
。179.5 s, 171.9 s, 162.5 s
.
160、I St 147,3 s、 143.I 5
s142.7 St 140,5 St 133,9
s。160, I St 147, 3 s, 143. I 5
s142.7 St 140,5 St 133,9
s.
124.1 d、 124.Os、 120.Os。124.1 d, 124. Os, 120. Os.
118.7 S、 116,7 d、 109,75t
105.3 d、 34.6 s、 S3.2 d。118.7 S, 116.7 d, 109,75t
105.3 d, 34.6 s, S3.2 d.
79.8 d、 79.I S、 77.5 d。79.8 d, 79. IS, 77.5 d.
70.9 cl、 、68,6 d、 62,8 d。70.9 cl, , 68,6 d, 62,8 d.
60.8 or 5!3,9 qw 52.6 qw5
2.2 q、 38,1 t、 23.9 Qt17.
8 a
(10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。60.8 or 5!3,9 qw 52.6 qw5
2.2 q, 38,1 t, 23.9 Qt17.
8 a (10) Color reaction: Positive for 10% sulfuric acid and molybdic acid reagents.
(11) IFH’l : メタノール、クロロ
ホルム、酢酸エチル、アセトンに溶け。(11) IFH'l: Soluble in methanol, chloroform, ethyl acetate, and acetone.
水に溶けない。Not soluble in water.
(12)薄層クロマトグラフィー:
担体シリカゲルプレート(メルク社製)展開溶媒系
Rf値
ヘキサン−アセトン(2:1) C)、2
7クロロホルムーメタノール(15:1) 0.4
0(13)塩基性、酸性、中性の区別: 弱酸性物質[
11]SF2446A3物質
(1)色及び形状: 赤褐色粉末
(2)元素分析値:C59,04%、 H4,12%。(12) Thin layer chromatography: Carrier silica gel plate (Merck & Co., Ltd.) developing solvent system
Rf value hexane-acetone (2:1) C), 2
7 Chloroform-methanol (15:1) 0.4
0(13) Distinction between basic, acidic, and neutral: Weakly acidic substances [
11] SF2446A3 substance (1) Color and shape: Reddish brown powder (2) Elemental analysis: C59.04%, H4.12%.
N 2,53%
(3)分子式 : C26H21NO□1(4)マ
ススペクトル(FD−MS) :+++/z 523
(M+)(5)融点 :>220°C
(6)紫外部及び可視部吸収スペクトル(第2図)λ1
Ilax r+m (E j風)
[MeOH] : 214 (587)、228sh
(461)。N 2,53% (3) Molecular formula: C26H21NO□1 (4) Mass spectrum (FD-MS): +++/z 523
(M+) (5) Melting point: >220°C (6) Ultraviolet and visible absorption spectra (Figure 2) λ1
Ilax r+m (E j style) [MeOH]: 214 (587), 228sh
(461).
258sh (321)、 272sh (270)。258sh (321), 272sh (270).
300sh (185)、412 (48)−[0,I
N IIcI−Neo旧: 216 (512)、2
30sh (400)。300sh (185), 412 (48)-[0,I
N IIcI-Neo old: 216 (512), 2
30sh (400).
255sh (321)、 275sh (260)。255sh (321), 275sh (260).
302sh (189)、 410 (63)。302sh (189), 410 (63).
[0,IN NaOH−MeO旧: 214 (11
60)、 232 (465)。[0,IN NaOH-MeO old: 214 (11
60), 232 (465).
300sh (193)、 460sh (31)。300sh (193), 460sh (31).
(7)光外部吸収スペクトル(第7図)(KBr cm
’): 3430.3400.2940.1720゜
1680、1650.1625.1590゜1465、
1410.1360.1310゜1265、1220.
1160.1120゜1090、1050.1000.
960゜940、・900. !1li75.815.
800(8)1HNMRスペクトル(400Mllz、
CDCl5)(第12図)
δ(ppm) : 2.40 (3L br sL
3,34 (IHt br dL3.40 (3H,s
)、 3.57 (ltl、 dd)−3,85(3H
,s)、 4.68 (IH,br d)=4.97
(IH,dd)、 5.24 (IH,br s)。(7) Optical external absorption spectrum (Figure 7) (KBr cm
'): 3430.3400.2940.1720°1680, 1650.1625.1590°1465,
1410.1360.1310°1265, 1220.
1160.1120°1090, 1050.1000.
960°940, 900. ! 1li75.815.
800(8)1H NMR spectrum (400Mllz,
CDCl5) (Figure 12) δ (ppm): 2.40 (3L br sL
3,34 (IHt br dL3.40 (3H,s
), 3.57 (ltl, dd) - 3,85 (3H
,s), 4.68 (IH,br d)=4.97
(IH, dd), 5.24 (IH, br s).
5.58 (2L’ br)、 5.95 (IL s
)+6.54 (IH,br s)、 8.20 (I
H,s)’。5.58 (2L' br), 5.95 (IL s
)+6.54 (IH, br s), 8.20 (I
H,s)'.
12.10 (IH,s)s 14.32 (1肌5)
(9)+3c NMRスペクトル(100M)12−
CDCl5)(第17図)
δ(ppm) : 196.3 St 190.OS
t 188,75t179.7 St 172.I S
、 162.3 s。12.10 (IH,s)s 14.32 (1 skin 5)
(9) +3c NMR spectrum (100M) 12-
CDCl5) (Figure 17) δ (ppm): 196.3 St 190. OS
t 188,75t179.7 St 172. IS
, 162.3 s.
160、I St 149.Os、 143.3 s。160, I St 149. Os, 143.3 s.
142.7 S、 140.0 s、 133.9 s
。142.7 s, 140.0 s, 133.9 s
.
124.3 d、 123.9 S、 119.7 s
。124.3 d, 123.9 S, 119.7 s
.
118.8 S、 116.2 d、 109.9 s
。118.8 S, 116.2 d, 109.9 s
.
104.3 d= 84.63.78,85t62.8
d、 52.6 Qt 52;3 q=38゜Ot+
23,9 q
(10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。104.3 d= 84.63.78, 85t62.8
d, 52.6 Qt 52;3 q=38°Ot+
23,9 q (10) Color reaction: Positive for 10% sulfuric acid and molybdic acid reagents.
(11) i8MH1: メタノール、クロロホル
ム、酢酸エチル、アセトンに溶け、
水に溶けない。(11) i8MH1: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water.
(12)薄層クロマトグラフィー:
担体シリカゲルプレート(メルク社製)展開溶媒系
RE値
値上キサンアセトン(2:1) 0.39クロロホ
ルム−メタノール(15:1) 0.42(13)塩
基性、酸性、中性の区別二 弱酸性物質[111]SF
2446B1物質
(1)色及び形状: 赤褐色粉末
(2)元素分析値:C59.04%、 )l 4.12
%、N 2.53%
(3)分子式 :C34H21NO11(4)マスス
ペクトル(FD−HS) :I11/’Z 682 (
MH”)(5)融点 : 188−192°C(
分解)(6)紫外部及び可視部吸収スペクトル(第3図
)λmax nm (Ej!、)
[MeOH] : 217 (624)、 230s
h (465)=252 (461)、 275sh
(341)。(12) Thin layer chromatography: Carrier silica gel plate (Merck & Co., Ltd.) developing solvent system
RE value upper
2446B1 substance (1) Color and shape: Reddish brown powder (2) Elemental analysis value: C59.04%, )l 4.12
%, N 2.53% (3) Molecular formula: C34H21NO11 (4) Mass spectrum (FD-HS): I11/'Z 682 (
MH”) (5) Melting point: 188-192°C (
Decomposition) (6) Ultraviolet and visible absorption spectra (Figure 3) λmax nm (Ej!,) [MeOH]: 217 (624), 230s
h (465)=252 (461), 275sh
(341).
305sh (170)、 419 (78)。305sh (170), 419 (78).
[0,IN IIcI−MeO旧: 218 (58
7)、227sh (461)。[0, IN IIcI-MeO old: 218 (58
7), 227sh (461).
252 (473)、 270sh (330)。252 (473), 270sh (330).
300sh (191)、 419 (87)。300sh (191), 419 (87).
[0,IN NaOH−MeO)1] : 215
(1230)、 246 (526)−3QO(195
)、 589 (129)(7)赤外部吸収スペクトル
(第8図)(KBr crn ’):3450.337
0.2940.2830゜1720、1675.165
0.1620゜1560、1510.1465.140
5゜1365、1310.1260.1240゜121
5、1160.1130.1110゜1085、105
0.1110.980゜950、920.885.86
0.815゜(8)1HNMRスペクトル(400M)
1z、 CDCl3)(第13図)
1 (ppm) : 1.35 (3)I、 d)、
2.24 (1)1. ddd)。[0,IN NaOH-MeO)1]: 215
(1230), 246 (526)-3QO (195
), 589 (129) (7) Infrared absorption spectrum (Figure 8) (KBr crn'): 3450.337
0.2940.2830°1720, 1675.165
0.1620°1560, 1510.1465.140
5゜1365, 1310.1260.1240゜121
5, 1160.1130.1110°1085, 105
0.1110.980°950, 920.885.86
0.815°(8)1HNMR spectrum (400M)
1z, CDCl3) (Figure 13) 1 (ppm): 1.35 (3)I, d),
2.24 (1)1. ddd).
2.33 (38,br s)t 2,63 (ltl
、 br d)。2.33 (38,br s)t 2,63 (ltl
,brd).
2.76 (IH,dclcl)、 3.08 (IH
,ddd)。2.76 (IH, dclcl), 3.08 (IH
, ddd).
3.14 (18,ddd)、 3.14 (IH,d
d)。3.14 (18,ddd), 3.14 (IH,d
d).
3.23 (3H,s)、 3.34 (1肌dq)t
3.61 (3)1. s)、3.70 (1)1.
dd)−3,75(IH9br ddd)、 3.80
(3tl、 s)。3.23 (3H,s), 3.34 (1 skin dq)t
3.61 (3)1. s), 3.70 (1)1.
dd) -3,75 (IH9br ddd), 3.80
(3tl, s).
3.82 (3H,s)t 4,69 (IH,dd)
。3.82 (3H,s)t 4,69 (IH,dd)
.
4.71 (ltl、 s)−5,86(ltl、 s
)。4.71 (ltl, s) - 5,86 (ltl, s
).
6.49 (IH,br s)t 6,84 (III
、 d)。6.49 (IH,br s)t 6,84 (III
, d).
8.21 (IH,s)t 12.04 (IH,5)
=14.15 (IH,5)
(9) 13CNMRスペクトル(100MHz、
CDCl5)(第18図)
δ(pp+o) : 197,7 St 190.3
91188,7 S。8.21 (IH,s)t 12.04 (IH,5)
=14.15 (IH, 5) (9) 13CNMR spectrum (100MHz,
CDCl5) (Figure 18) δ(pp+o): 197.7 St 190.3
91188,7S.
179.4 St 172.I St 162.4 s
。179.4 St 172. I St 162.4 s
.
160.2 St 147.1 s、 145.I 5
t142.4 S、 140,9 S、 133,7
S。160.2 St 147.1 s, 145. I 5
t142.4 S, 140.9 S, 133.7
S.
124、L d、 124.OS、 120.95t1
18.43= 116.4 d、 109.4 S。124, L d, 124. OS, 120.95t1
18.43 = 116.4 d, 109.4 S.
104.2 d、 87.1 s、 82.8 d。104.2 d, 87.1 s, 82.8 d.
79.6 d、 79,2 d、 77.95t75.
2 d、 73.3 d、 62,5 q。79.6 d, 79.2 d, 77.95t75.
2 d, 73.3 d, 62.5 q.
61.2 Qt 52J qt 52,2 Q+26.
7 t+ 23.S q、18,4 L+IS、Oq
(10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。61.2 Qt 52J qt 52,2 Q+26.
7 t+ 23. S q, 18,4 L+IS, Oq (10) Color reaction: Positive for 10% sulfuric acid and molybdate reagent.
(11) 1解性: メタノール、クロロホルム、
酢酸エチル、アセトンに溶け、
水に溶けない。(11) Monolysis: methanol, chloroform,
Soluble in ethyl acetate and acetone, insoluble in water.
(12)薄層クロマトグラフィー:
担体シリカゲルプレート(メルク社製)展開溶媒系
Rf値ヘキサン−アセトン(2:1
) 0.43クロロホルム−メタノール
(15:1) 0.58(13)塩基性、酸性、
中性の区別二 弱酸性物質[IV]SF2446B2物
質
(1)色及び形状; 赤褐色粉末
(2)元素分析値: C59.04%、 H4.12
%、82.05%
(3)分子式 :C34H21NO11(4)マスス
ペクトル(FD−HS) :m/z 681 (M”)
(5)融点 : 177−181℃ (分解)(
6)紫外部及び可視部吸収スペクトル(第4図)λma
x nm (13
[MeOHl : 217 (617L 22Ssh
(470)。(12) Thin layer chromatography: Carrier silica gel plate (Merck & Co., Ltd.) developing solvent system
Rf value hexane-acetone (2:1
) 0.43 chloroform-methanol (15:1) 0.58 (13) basic, acidic,
Neutral distinction 2 Weak acidic substance [IV] SF2446B2 Substance (1) Color and shape; Reddish brown powder (2) Elemental analysis value: C59.04%, H4.12
%, 82.05% (3) Molecular formula: C34H21NO11 (4) Mass spectrum (FD-HS): m/z 681 (M”)
(5) Melting point: 177-181℃ (decomposition) (
6) Ultraviolet and visible absorption spectra (Figure 4) λma
x nm (13 [MeOHl: 217 (617L 22Ssh
(470).
250 (455)、 270sh (355)。250 (455), 270sh (355).
300sh (19F)、 418 (84)。300sh (19F), 418 (84).
[0,IN HClHe0tll : 218 (5
86)、 227sh (461)。[0, IN HClHe0tll : 218 (5
86), 227sh (461).
251 (464)、 270sh (370)。251 (464), 270sh (370).
305sh (181)、 416 (85)。305sh (181), 416 (85).
[0,IN NaOH−MeOIl] : 214 (
1180)、 246 (511)。[0,IN NaOH-MeOIl]: 214 (
1180), 246 (511).
300 (195)、 585 (128)(7)光外
部吸収スペクトル(第9図)(KBr c+++ ’)
:3430.2930.2330.1720゜1680
、1650.1620.1590゜1560、1515
.1465.1405゜1365、1310.1265
.1240゜1215、1165.1100.1040
゜1020、995.950.920.885゜810
、800
(8) 1HNMRスペクトル(400Hilz 、C
DCI 3 )(第14図)
δ(ppm) : 1.27 (3H,d)、 2.
26 (IH,ddd)。300 (195), 585 (128) (7) Optical external absorption spectrum (Figure 9) (KBr c+++')
:3430.2930.2330.1720°1680
, 1650.1620.1590°1560, 1515
.. 1465.1405°1365, 1310.1265
.. 1240°1215, 1165.1100.1040
゜1020, 995.950.920.885゜810
, 800 (8) 1H NMR spectrum (400 Hilz, C
DCI 3 ) (Figure 14) δ (ppm): 1.27 (3H, d), 2.
26 (IH, ddd).
2.37 (3)1. br s)、 2.65 (I
H,d)。2.37 (3)1. br s), 2.65 (I
H, d).
2.77 (11(、ddd)、 3.08 (ill
、 ddd)。2.77 (11(,ddd), 3.08 (ill
, ddd).
3.10 (IH,dd)、 3.12 (IH,dd
d)。3.10 (IH, dd), 3.12 (IH, dd
d).
3.25 (3fl、 s)、 3.50 (3H,d
q)。3.25 (3fl, s), 3.50 (3H, d
q).
3.55 (3日、 s)、 3.56 (3H,s)
。3.55 (3 days, s), 3.56 (3H, s)
.
3.68 (ltl、 dd)、 3.80 (3H,
sL4.02 (IH,ddcl)、 4.86 (l
tl、 5)−5,19(IH,dd)、 6.19
(IH,5)=6.40 (IH,d)、 6.50
(IH,br 5)s8.34 (18,s)、12.
06 (IH,5)t14.19 (IH,5)
(9) 13CNMRスベク)ル(IQOt4tlz
、CDCl3)(第19図)
δ(ppm) : 198.I S、 190,2
s、 188,751179.6 s、 172.I
S、 162,5 s。3.68 (ltl, dd), 3.80 (3H,
sL4.02 (IH, ddcl), 4.86 (l
tl, 5)-5,19 (IH, dd), 6.19
(IH, 5) = 6.40 (IH, d), 6.50
(IH, br 5) s8.34 (18, s), 12.
06 (IH, 5) t14.19 (IH, 5) (9) 13CNMR Subekle (IQOt4tlz
, CDCl3) (Fig. 19) δ (ppm): 198. IS, 190,2
s, 188,751179.6 s, 172. I
S, 162,5 s.
160.2 St 147,3 s、 145.O5t
142.4 Ss 141.2 S、 133,75t
124.2 d、 124.I S、 120,9 s
。160.2 St 147,3 s, 145. O5t
142.4 Ss 141.2 S, 133,75t
124.2 d, 124. IS, 120,9 s
.
118.4 S、 116.8 d、 109.59t
105.5 d= 87.2 s、 83.Od。118.4 S, 116.8 d, 109.59t
105.5 d= 87.2 s, 83. Od.
79.8 +L 78.I Ss 77.5 d。79.8 +L 78. I Ss 77.5 d.
70.8 d、68.7460.7 Qs58.9 Q
t 52,3 q* 52,2 Q+26.7 ty
23,9 q+ IS、5 ltl7.7 q
(10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。70.8 d, 68.7460.7 Qs58.9 Q
t 52,3 q* 52,2 Q+26.7 ty
23.9 q+ IS, 5 ltl7.7 q (10) Color reaction: Positive for 10% sulfuric acid and molybdate reagent.
(11) i8解性: メタノール、クロロホルム
、酢酸エチル、アセトンに溶け、
水に溶けない。(11) i8 Solubility: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water.
(12)薄層クロマトグラフィー:
担体シリカゲルプレート(メルク社製)展開溶媒系
Rf値
ヘキサン−アセトン(2:1) 0,35
クロロホルム−メタノール(15:1) 0.45
(13)塩基性、酸性、中性の区別二 弱酸性物質[V
]SF2446B3物質
(1)色及び形状: 赤褐色粉末
(2)分子式 :C26112、NOo。(12) Thin layer chromatography: Carrier silica gel plate (Merck & Co., Ltd.) developing solvent system
Rf value hexane-acetone (2:1) 0,35
Chloroform-methanol (15:1) 0.45
(13) Distinction between basic, acidic, and neutral Weakly acidic substances [V
] SF2446B3 substance (1) Color and shape: Reddish brown powder (2) Molecular formula: C26112, NOo.
(3)マススペクトル(FD−MS) : m/z 5
07 (H”)(4)融点 : 187−192
℃
(5)紫外部及び可視部吸収スペクトル(第5図)λm
ax nm (IL)
[Me111] : 217 (680)、 227
sh (517)。(3) Mass spectrum (FD-MS): m/z 5
07 (H”) (4) Melting point: 187-192
℃ (5) Ultraviolet and visible absorption spectra (Figure 5) λm
ax nm (IL) [Me111]: 217 (680), 227
sh (517).
251 (464)、 275sh (345)。251 (464), 275sh (345).
300sh (231)、 409 (87)。300sh (231), 409 (87).
[0,IN IIcI−Me111] : 213
(645)、 227sh (511)。[0, IN IIcI-Me111]: 213
(645), 227sh (511).
251 (473)、 272sh (361)=30
0sh (241)、 410 (91)。251 (473), 272sh (361) = 30
0sh (241), 410 (91).
[0,IN NaOH−MeOt!] : 215
(1220)、 240sh (511)。[0, IN NaOH-MeOt! ] : 215
(1220), 240sh (511).
285sh (245)、 460 (47)。285sh (245), 460 (47).
(6)光外部吸収スペクトル(第10図)(KBr a
m ’) : 3440,33eo、 2950+ 1
72(Ltess、 1e5o、 16251159(
L1465、1405.1360.1310゜1260
、1220.1165.1105゜1080、1050
.1005.955゜915、890.815.800
(7) 1HNMRxヘク) ル(400MHz、
CDCIz)(第15図)
δ(pp+n) ’、 2.27 (IL ddd)+
2.38 (31L br s)+2.76 (lt
l、 ddd)、3.O8(IH,ddd)。(6) Optical external absorption spectrum (Figure 10) (KBr a
m'): 3440, 33eo, 2950+1
72(Ltess, 1e5o, 16251159(
L1465, 1405.1360.1310°1260
, 1220.1165.1105゜1080, 1050
.. 1005.955°915, 890.815.800 (7) 1HNMR x hexle (400MHz,
CDCIz) (Figure 15) δ(pp+n)', 2.27 (IL ddd)+
2.38 (31L br s) + 2.76 (lt
l, ddd), 3. O8 (IH, ddd).
3.15 (IH,ddd)、 3.23 (3H,s
)。3.15 (IH, ddd), 3.23 (3H, s
).
3.84 (311,s)、4.70 (III、 s
)。3.84 (311, s), 4.70 (III, s
).
5.43 (2H,br)、 5.94 (1)1.5
)−6,51(IH,br s)、 8.22 (1肌
5L12.06 (IH,s)t 14.25 (IH
,5)(8)1コCNMRスヘ9 トル(100Mtl
z、 CDCl、)(第20図)
δ(ppm) : 197.9 St 190,3
Sl 188,85s179.8 S、 172,2
St 162,4 S。5.43 (2H, br), 5.94 (1) 1.5
)-6,51 (IH,br s), 8.22 (1 skin 5L12.06 (IH,s)t 14.25 (IH
, 5) (8) 1 piece CNMR 9 torr (100Mtl
z, CDCl, ) (Figure 20) δ (ppm): 197.9 St 190,3
Sl 188,85s179.8 S, 172,2
St 162,4 S.
160.3 s、 148,9 S、 145.1 s
。160.3 s, 148.9 s, 145.1 s
.
142.4 St 140.9 S、 133,7 s
。142.4 St 140.9 S, 133,7 s
.
124.2 d、 124.1 s、 120.9 s
。124.2 d, 124.1 s, 120.9 s
.
118.6 s、 116.4 d、 109,5 s
。118.6 s, 116.4 d, 109.5 s
.
104.5 d、 87.I S、 7S、OS。104.5 d, 87. IS, 7S, OS.
52.3 x2 q、 26.8 t。52.3 x2 q, 26.8 t.
23.9 (i、18.5 t
(9)呈色反応:10%硫酸、モリブデン酸試薬に陽性
である。23.9 (i, 18.5 t (9) Color reaction: Positive for 10% sulfuric acid and molybdate reagent.
(10) 溶解性: メタノール、クロロホルム、
酢酸エチル、アセトン・に溶け、
水に溶けない。(10) Solubility: methanol, chloroform,
Soluble in ethyl acetate and acetone, insoluble in water.
(11)薄層クロマトグラフィー:
担体シリカゲルプレート(メルク社製)展開溶媒系
Rf値
ヘキサン−アセトン(2:1) 0.46
クロロホルムーメタ7−ル(15:1) 0.50
(12)塩基性、酸性、中性の区別二 弱酸性物質本願
発明物質の化学構造式は下記の様に推定された。(11) Thin layer chromatography: Carrier silica gel plate (Merck & Co., Ltd.) developing solvent system
Rf value hexane-acetone (2:1) 0.46
Chloroform-metal-7-ol (15:1) 0.50
(12) Distinction between basic, acidic, and neutral Weakly acidic substances The chemical structural formula of the present invention substance was estimated as follows.
本発明に使用される新規抗生物質の生産菌の一例として
は、兵庫県の土壌から新たに分離されたSF2446株
がある。An example of a new antibiotic-producing bacterium used in the present invention is strain SF2446, which was newly isolated from the soil of Hyogo Prefecture.
SF2446株の菌学的性状は下記の通りである。The mycological properties of SF2446 strain are as follows.
■、形 態
基生菌糸は長く伸張し、よく分岐し9通常の条件下では
分断しない。気菌糸の着生は貧弱であるが、オートミー
ル寒天、又ターチ寒天、グリセロール・アスパラギン寒
天、シュクロース・硝酸塩寒天等で着生し、胞子形成も
認められる。気菌糸の分岐は単純分岐で車軸分岐は見ら
れない。気菌糸先端の胞子連鎖は波状、ループ状、フッ
ク状。■ Morphology The basal hyphae are elongated, well branched, and do not divide under normal conditions. Although the aerial mycelium is poorly attached, it can be attached to oatmeal agar, turch agar, glycerol/asparagine agar, sucrose/nitrate agar, etc., and spore formation is also observed. The branching of aerial hyphae is simple, and no axle branching is observed. Spore chains at the tips of aerial hyphae are wavy, loop-shaped, and hook-shaped.
あるいは不完全な螺旋状となる。電子顕微鏡による観察
では、胞子は円筒型ないし楕円型で、0.5〜1.IX
o、6〜1.3μmの大きさを有し1表面はしわ状(r
ugose)ないし刺状(spiny)である。胞子は
通常50個以上連鎖する。胞子量、運動性胞子、菌核等
は観察されない。Or it becomes an incomplete spiral. When observed using an electron microscope, the spores are cylindrical to elliptical and have a size of 0.5 to 1. IX
o, has a size of 6 to 1.3 μm, and one surface is wrinkled (r
It is ugose or spiny. Spores usually form chains of 50 or more. No amount of spores, motile spores, sclerotia, etc. were observed.
■、各種培地上の生育状態
SF2446株の各種培地上の生育状態は第1表に示す
通りである。色の記載について[1内に示す標準はコン
ティーナー・コーポレーション・オブ・アメリカ(Co
ntainer Corporation ofAme
rica)社lの[カラー争ハーモニー中マニアル(C
olor Harmony Maumal)Jに記載さ
れているものを用いた。観察は28°Cで14〜21日
間培養後に行なった。(2) Growth status on various media The growth status of SF2446 strain on various media is shown in Table 1. Regarding color descriptions [The standards shown in 1 are from Container Corporation of America (Co
ntainer Corporation of Ame
rica) company's [Color Competition Harmony Medium Manual (C
The one described in Color Harmony Maumal) J was used. Observations were made after culturing at 28°C for 14-21 days.
■、生理的性質
(1)生育温度範囲:イースト麦芽寒天において20〜
37℃の温度範囲で生育し、26〜30’Cで良好に生
育する。■Physiological properties (1) Growth temperature range: 20~20°C on yeast malt agar
It grows in a temperature range of 37°C and grows well at 26-30'C.
(2)ゼラチンの液化:陰性
(3)スターチの加水分解:陰性
(4)硝酸塩の還元:陰性
(5)脱脂乳のペプトン化:陰性
脱脂乳の凝固:陰性
(6)耐塩性:4%の食塩含有培地では生育するが、5
%以上では生育しない。(2) Liquefaction of gelatin: Negative (3) Hydrolysis of starch: Negative (4) Reduction of nitrate: Negative (5) Peptonization of skim milk: Negative Coagulation of skim milk: Negative (6) Salt tolerance: 4% Although it grows in a salt-containing medium, 5
It will not grow above %.
(7)メラニン様色素の生成:陰性
■、炭素源の利用性(ISP No、9培地使用)(
1)利用する :D−グルコース、グリセロール(2)
利用しない:D−キシロース、L−アラビノース、D−
マン二F−ル、i−イノシトール、ラフィノース、シュ
クロース
(3)利用が疑わしい一〇−7ラクトース、し−ラムノ
ース
■、細胞壁組成
ベツカ−(Becker)らの方法(Appl、Mic
robiol、11+236、1965)により分析し
た結果、細胞壁M戒成分中のジアミノピメリン酸はLL
型であつrこ。(7) Production of melanin-like pigment: negative ■, carbon source availability (ISP No. 9 medium used) (
1) Use: D-glucose, glycerol (2)
Not used: D-xylose, L-arabinose, D-
Mannyl, i-inositol, raffinose, sucrose (3) 10-7 lactose, sucrose (3) whose use is suspected, cell wall composition Becker et al.'s method (Appl, Mic
As a result of analysis using LL.
It's a type.
以上の性状より、SF2446株は放線菌の中でストレ
プトマイセス属に属すると考えるのが妥当である。従っ
て1本発明者らはSF2446株を又トレプFマイセス
・エスピー・SF2446(Streptomyces
sp、 S F 2446 )と称することにした。Based on the above properties, it is reasonable to consider that strain SF2446 belongs to the genus Streptomyces among actinomycetes. Therefore, the present inventors also used the SF2446 strain as TrepF Myces sp. SF2446 (Streptomyces sp.
sp, SF 2446).
SF2446株は工業技術院微生物工業技術研究所に微
工研菌寄第8980号(FERN P−8980)とし
て受託されている。Strain SF2446 has been entrusted to the Institute of Microbial Technology, Agency of Industrial Science and Technology as Fiber Science and Technology Research Institute No. 8980 (FERN P-8980).
SF2446株は池の放線菌の場合に見られるように、
その性状が変化しやすい。例えば、SF2446株の、
またはこの株に由来する突然変異株(自然発生または誘
発性)、形質接合体または遺伝子組み換え体であっても
1本願にかかわる抗生物質を生産するものは全て本発明
に使用できる。As seen in the case of actinomycetes in ponds, the SF2446 strain
Its properties change easily. For example, of SF2446 strain,
Alternatively, any mutant strain (naturally occurring or induced), transconjugant, or genetically modified strain derived from this strain that produces the antibiotic according to the present application can be used in the present invention.
本発明の方法では、前記の菌を通常の微生物が利用しう
る栄養物を含有する培地で培養する。栄養源としては、
グルコース、水飴、デキストリン。In the method of the present invention, the above bacteria are cultured in a medium containing nutrients that can be used by common microorganisms. As a source of nutrients,
Glucose, starch syrup, dextrin.
シュクロース、澱粉、糖蜜、動・植物油等を使用出来る
。また窒素源として、大豆粉、小麦胚芽。Sucrose, starch, molasses, animal/vegetable oils, etc. can be used. Soy flour and wheat germ are also used as nitrogen sources.
コーンステイブリカー、綿実粕、肉エキス、ペプトン、
酵母エキス、硫酸アンモニウム、硝酸ソーダ、尿素等を
使用出来る。その池、必要に応じてナトリウム、カリウ
ム、マグネシウム、コバルF。Corn stable liquor, cottonseed meal, meat extract, peptone,
Yeast extract, ammonium sulfate, sodium nitrate, urea, etc. can be used. The pond, sodium, potassium, magnesium, Kobal F as needed.
塩素、燐酸、硫酸、及びその池のイオンを生しることが
できる黒磯塩類を添加することは有効である。また菌の
発育を助け9本願にかかわる抗生物質の生産を促進する
ような有機及び無機物を適当に添加することができる。It is effective to add Kuroiso salts that can generate chlorine, phosphoric acid, sulfuric acid, and their ions. In addition, organic and inorganic substances that aid the growth of bacteria and promote the production of the antibiotics involved in the present application can be appropriately added.
培養法としては、好気的条件での培養法、特に深部培養
法が最も適している。培養に適当な温度は20〜37°
Cであるが、多くの場合26〜30℃付近で培養する。The most suitable culture method is a culture method under aerobic conditions, especially a deep culture method. The appropriate temperature for culturing is 20-37°.
C, but in most cases it is cultured at around 26-30°C.
本願にかかわる抗生物質の生産は培地や培養条件により
異なるが、振盪培養、タンク培養とも通常1〜8日の間
でその蓄積が最高に達する。培養液中の本願にかかわる
抗生物質の蓄積量が最高になっすこ時に培養を停止し、
培養液から目的物質を単離精製する。Although the production of the antibiotic related to the present application differs depending on the culture medium and culture conditions, the accumulation usually reaches its maximum within 1 to 8 days in both shaking culture and tank culture. Stop the culture when the accumulated amount of the antibiotic related to the present application in the culture solution reaches its maximum,
Isolate and purify the target substance from the culture solution.
このようにして生産される本願抗生物質は前記の理化学
的性状を有するので、その性状に従って培養液から抽出
、精製することが可能であるが。Since the antibiotic of the present invention produced in this manner has the above-mentioned physicochemical properties, it can be extracted and purified from the culture solution according to the properties.
特に以下に述べる方法により効率的に抽出、精製するこ
と力咄来る。すなわち、有効成分を含有する培養液に酢
酸エチル等の水と自由に混和しない有機溶媒を加えて攪
拌、抽出する。一方、固形物はアセトン等の水と自由に
混和する有機溶媒と水を加えて攪拌し、固形分から有効
成分を抽出し。In particular, it is recommended that it be efficiently extracted and purified by the method described below. That is, an organic solvent that is not freely miscible with water, such as ethyl acetate, is added to the culture solution containing the active ingredient, followed by stirring and extraction. On the other hand, the solid substance is mixed with water and an organic solvent such as acetone that is freely miscible with water, and the active ingredients are extracted from the solid substance.
有機溶媒を留去した後、酢酸エチル等の水と自由に混和
しない有機溶媒を用いて有効成分を抽出する。このよう
にして得られた油状物質をシリカゲル、アルミナ、ゲル
濾過剤等の担体を適宜組み合わせたクロマトグラフィー
lこより本願抗生物質を単離する。After distilling off the organic solvent, the active ingredient is extracted using an organic solvent that is not freely miscible with water, such as ethyl acetate. The antibiotic of the present invention is isolated by chromatography of the thus obtained oily substance using a suitable combination of carriers such as silica gel, alumina, and gel filtration agents.
発明の効果
本発明にかかわる抗生物質は主としてダラム陽性の一般
細菌及びマイコプラズマに対して強い抗菌作用を有する
。一般細菌では日本化学療法学会法の寒天平板希釈法(
ChemoLherapy29t 76−79.198
1)に従い、マイコプラズマではPPLOブロス培地を
使用した液体希釈法(Chemotherapy23+
2569−2576、1975)に準じて測定した抗
生物質SF2446物質、SF2446A2物質、SF
2446A3物質、SF2446B1物質、SF244
6B2物質及びSF2446B3物質の各種微生物に対
する最小発育阻止濃度(MIC)は第2表に示す通りで
ある。Effects of the Invention The antibiotic according to the present invention has a strong antibacterial effect mainly against Durum-positive general bacteria and mycoplasma. For general bacteria, the agar plate dilution method according to the Japanese Society of Chemotherapy (
ChemoLtherapy29t 76-79.198
According to 1), for mycoplasma, liquid dilution method using PPLO broth medium (Chemotherapy 23+
Antibiotics SF2446 substance, SF2446A2 substance, SF measured according to 2569-2576, 1975)
2446A3 substance, SF2446B1 substance, SF244
The minimum inhibitory concentrations (MIC) of the 6B2 substance and SF2446B3 substance against various microorganisms are shown in Table 2.
実施例1
種培地として、スターチ2.0%、グルコース1.0%
、小麦胚芽0.6%、ポリペプトン0.5%、酵母エキ
ス0.3%、大豆粉0.2%、炭酸カルシウム0.1%
を含む培地を用いた。また生産培地として、グルコース
3.0%、小麦胚芽1.5%、大豆粉0.5%。Example 1 Starch 2.0%, glucose 1.0% as seed medium
, wheat germ 0.6%, polypeptone 0.5%, yeast extract 0.3%, soy flour 0.2%, calcium carbonate 0.1%
A medium containing the following was used. In addition, as a production medium, glucose 3.0%, wheat germ 1.5%, and soybean flour 0.5%.
コーンステイープリカー1.0%、炭酸カルシウム0.
1%、塩化コバル)0.011%を含む培地を用いた。Corn staple liquor 1.0%, calcium carbonate 0.
A medium containing 0.011% (cobal chloride) was used.
なお、殺菌前pHはすべでpH7,0に調整した。In addition, the pH before sterilization was adjusted to pH 7.0 in all cases.
前記種培地20m1を分注した100n+ l容三角7
ラスフを120℃で30分間殺菌し、これにストレプト
マイセス・エスピー・SF2446(FERN P−8
980)の斜面培養の1−2白金耳を接種し、28°C
で3日間振どう培養し第1種培養とした。次いで種培地
80n+ lを分注した500+++ l容三角フラス
コを120℃で30分間殺菌し、前記第1種培養4+a
lを接種後、28℃で2日間振どう培養して、これを第
2種培養とした。更に種培地ILを分注した5L容三角
フラスコを120″Cで30分間殺菌し、第2種培養5
0m lを接種後、28°Cで1日間振どう培養して、
これを第3種培養とした。更に予め120°Cで30分
間殺菌した種培地25Lを分注した50L容ジヤー77
メンターに、第2種培養50を接種し、28°Cで1日
間通気攪拌琺養し、これを第4種培養とした。100n+l volume triangular 7 into which 20ml of the seed medium was dispensed
Sterilize Rasph at 120°C for 30 minutes, and add Streptomyces sp. SF2446 (FERN P-8
980) was inoculated with 1-2 platinum loops of slant culture, and incubated at 28°C.
The cells were cultured with shaking for 3 days to form a type 1 culture. Next, a 500+++ l Erlenmeyer flask into which 80 n+ l of the seed medium was dispensed was sterilized at 120°C for 30 minutes, and the first type culture 4+a was
After inoculation, the cells were cultured with shaking at 28° C. for 2 days, and this was used as a second type culture. Furthermore, the 5L Erlenmeyer flask into which the seed medium IL was dispensed was sterilized at 120"C for 30 minutes, and the second seed culture 5
After inoculating 0ml, culture with shaking at 28°C for 1 day.
This was designated as type 3 culture. Furthermore, 50L jar 77 was dispensed with 25L of seed medium that had been sterilized in advance at 120°C for 30 minutes.
Mentor was inoculated with 50 seeds of the 2nd type culture and incubated with aeration at 28°C for 1 day, which was used as the 4th type culture.
予め120°Cで30分間殺菌した20OLの生産培地
を含む300L容ジヤーフアメンターに、前記の第4種
培養25Lを接種し、28°Cで5日間通気(20L/
分)、攪拌(初期100r100rp時間以降130r
p+n)培養した。培養終了後、濾過助剤として珪藻土
を加え濾過した。A 300L jar fermenter containing 20OL of production medium previously sterilized at 120°C for 30 minutes was inoculated with 25L of the above-mentioned type 4 culture, and aerated (20L/20L) at 28°C for 5 days.
minutes), stirring (initial 100r, 130r after 100rp time)
p+n) was cultured. After the culture was completed, diatomaceous earth was added as a filter aid and filtered.
濾過後に得られた菌体を含む固形分に70%アセトン水
158Lを加えて1時間攪拌し、再び濾過して有効成分
を含む菌体抽出液158Lを得た。更に菌体抽出液を減
圧濃縮してアセトンを留去した水層54LをpH7に調
整し、酢酸エチル54Lを加えて1時間攪拌して有効成
分を抽出した。この挽作を2回繰り返し、得られた酢酸
エチル抽出液に無水硫酸ナトリウムを加えて乾燥後、約
2Lまで減圧濃縮した。158 L of 70% acetone water was added to the solid content containing bacterial cells obtained after filtration, stirred for 1 hour, and filtered again to obtain 158 L of bacterial cell extract containing active ingredients. Furthermore, the bacterial cell extract was concentrated under reduced pressure to remove acetone, and the aqueous layer (54 L) was adjusted to pH 7, and 54 L of ethyl acetate was added thereto and stirred for 1 hour to extract the active ingredients. This grinding process was repeated twice, and anhydrous sodium sulfate was added to the obtained ethyl acetate extract to dry it, and the extract was concentrated under reduced pressure to about 2 L.
濃縮液は5℃で1週間放置後、析出した結晶を濾別し、
冷メタノール次いでヘキサンで洗浄して乾燥すると、8
.59gのSF2446物質が得られた。この濾液と洗
浄液を合わせて減圧濃縮すると、赤褐色の油状物質が得
られた。The concentrated solution was left at 5°C for one week, and the precipitated crystals were filtered out.
After washing with cold methanol and then hexane and drying, 8
.. 59 g of SF2446 material was obtained. The filtrate and washings were combined and concentrated under reduced pressure to obtain a reddish-brown oily substance.
この油状物質をクロロホルムで予め充填したシリカゲル
カラム2,4L(ワコーデルC・300.和光純薬社製
)の上部にのせ、クロロホルム5Lで洗浄後。This oily substance was placed on the top of a 2.4 L silica gel column (Wacodel C 300, manufactured by Wako Pure Chemical Industries, Ltd.) that had been filled with chloroform in advance, and washed with 5 L of chloroform.
クロロホルム−メタノール(10: 1 )で展開シて
活性画分を集め減圧濃縮すると、油状物質が得られた。The active fractions were developed with chloroform-methanol (10:1) and concentrated under reduced pressure to obtain an oily substance.
この操作を2回繰り返し、得られた油状物質を同様のシ
リカゲルカラム2.4Lの上部にのせ、クロロホルムI
Lで洗浄後、クロロホルム−メタノール(50:1)、
200m17ラクシヨンカツトで展開すると。This operation was repeated twice, the resulting oily substance was placed on top of a similar 2.4 L silica gel column, and chloroform I
After washing with L, chloroform-methanol (50:1),
When expanded with a 200m17 lux cut.
7ラク、9 ン3〜6(Fr、 I )にSF2446
B1物質を主に含む活性区が、フラクション7〜14(
Fr、 II )にSF2446物質及びSF2446
八3物質を主に含む活性区が、7ラクシヨン15〜18
(Fr、 m )にSF2446B2物質を主に含む活
性区が、7ラクシヨン19〜28(Fr、 IV )及
び7ラクシヨン29〜40(Fr、V)にSF2446
A2物質を主に含む活性区が得られた。Fr、 Iを減
圧濃縮乾固すると、650n+gの油状物質が得られた
。この油状物質を予めヘキサン−アセトン(2:1)で
充填したシリカゲルカラム120m1の上部にのせ、同
様の溶媒系で展開すると、 SF2446B1物質を主
に含む親物質が得られた。この親物質を更に分取用シリ
カゲルTLC(展開系:ヘキサン−アセトン1:1)で
精製するとt 80.5mgのSF2446B1物質が
得られた。Fr。SF2446 for 7 Lacs, 9 N3-6 (Fr, I)
The active area mainly containing B1 substances is fractions 7 to 14 (
Fr, II) with SF2446 substance and SF2446
The active area mainly containing 83 substances is 7 lactones 15 to 18.
The active area mainly containing SF2446B2 substance in (Fr, m) is the active region containing SF2446B2 substance in 7-lactation 19-28 (Fr, IV) and 7-lactation 29-40 (Fr, V).
An active area containing mainly A2 substance was obtained. Fr, I was concentrated to dryness under reduced pressure to obtain 650 n+g of an oily substance. This oily substance was placed on top of a 120 ml silica gel column previously filled with hexane-acetone (2:1) and developed with the same solvent system to obtain a parent substance containing mainly SF2446B1 substance. This parent substance was further purified by preparative silica gel TLC (developing system: hexane-acetone 1:1) to obtain 80.5 mg of SF2446B1 substance. Fr.
■を減圧濃縮乾固すると、 10.51gの親物質が得
られた。この親物質をクロロホルム−メタノール(1:
1)混液を用いて再結晶を行うと? 1.828のSF
2446物質が得られた。濾液を)減圧濃縮し、得られ
た親物質はクロロホルム−メタノール(1:1)を展開
溶媒とするセフ7デツクスLH−20(750ml、
Pharmacia社製)のカラムクロマトグラフィー
を行い、活性画分を減圧濃縮乾固した。更にこの繰作を
2回繰り返すとs 570mgのSF2446物質及び
303mgの主にSF2446^3物質を含む親物質が
得られた。この親物質をシリカゲルカラム(30g*展
開系:量系ロホルムーメタノール30: 1 )次いで
分取用シリカゲルカラムT L C(7[系:クロロホ
ルムーメタノール15: 1 )で精製すると、 23
.7mgのSF2446A3物質が得られた。Fr、
IIIを減圧濃縮乾固すると、772Hの親物質が得ら
れた。この親物質はクロロホルム−メタノール(30:
1 )を展開溶媒とするシリカゲル(80g)カラム
クロマトグラフィーを行い、得られた活性画分を減圧濃
縮乾固すると、 123mgの親物質が得られた。更に
この親物質を分取用シリカゲルTLC(展開系:トルエ
ンー酢酸エチル1:2゜次いでクロロホルム−メタノー
ル15: 1 )で精製すると+ 78.81111?
のSF2446B2物質が得られた。Fr。(2) was concentrated to dryness under reduced pressure to obtain 10.51 g of the parent substance. This parent substance was mixed with chloroform-methanol (1:
1) What if you perform recrystallization using a mixed solution? SF of 1.828
2446 substances were obtained. The filtrate) was concentrated under reduced pressure, and the obtained parent substance was purified using Cef7dex LH-20 (750 ml,
Column chromatography (manufactured by Pharmacia) was performed, and the active fraction was concentrated to dryness under reduced pressure. This process was repeated twice to obtain 570 mg of SF2446 substance and 303 mg of parent substance containing mainly SF2446^3 substance. This parent substance was purified using a silica gel column (30 g*Developing system: chloroform-methanol 30:1) and then using a preparative silica gel column TLC (7 system: chloroform-methanol 15:1), resulting in 23
.. 7 mg of SF2446A3 material was obtained. Fr,
III was concentrated to dryness under reduced pressure to obtain the parent material of 772H. This parent substance is chloroform-methanol (30:
Column chromatography was performed on silica gel (80 g) using 1) as a developing solvent, and the obtained active fraction was concentrated to dryness under reduced pressure to obtain 123 mg of the parent substance. When this parent substance was further purified by preparative silica gel TLC (developing system: toluene-ethyl acetate 1:2°, then chloroform-methanol 15:1), the result was +78.81111?
SF2446B2 material was obtained. Fr.
■を減圧濃縮乾固すると、5.071?(7)SF24
46A2物質が得られた。同様にFr、Vを減圧濃縮乾
固すると、5゜72gの親物質が得られた。この親物質
はシリカゲル(300g、 H量系:クロロホルム−メ
タノール50:1)カラムクロマトグラフィー、次いで
シリカゾル(300g、展開系:ヘキサン−アセトン
2:1)カラムクロマトグラフィー、更にセファデック
スLH−20(展開系:クロロホルム−メタノール1:
1)カラムクロマトグラフィーを行い、1.13HのS
F2446A2物質が得られた。When ■ is concentrated to dryness under reduced pressure, it is 5.071? (7) SF24
46A2 material was obtained. Similarly, Fr and V were concentrated to dryness under reduced pressure to obtain 5.72 g of the parent substance. This parent substance was subjected to column chromatography on silica gel (300 g, H amount system: chloroform-methanol 50:1), then silica sol (300 g, developing system: hexane-acetone).
2:1) column chromatography, and further Sephadex LH-20 (developing system: chloroform-methanol 1:
1) Perform column chromatography to remove 1.13H S
F2446A2 material was obtained.
実施例2
SF2446B1物質(15,2+ng)のメタノール
溶i(2,2m1)に濃塩酸(0,2m l )を加え
て、40°Cで1時間放置した。Example 2 Concentrated hydrochloric acid (0.2 ml) was added to methanol solution (2.2 ml) of SF2446B1 substance (15.2+ng) and left at 40°C for 1 hour.
その後、減圧下に溶媒を留去し、残香を分取用シリカゲ
ルTLC(展開系:クロロホルム−メタノール15:
1 )で精製すると、 5.4mgのSF2446B3
物質が得られた。Thereafter, the solvent was distilled off under reduced pressure, and the residual aroma was analyzed by preparative silica gel TLC (developing system: chloroform-methanol 15:
1), 5.4 mg of SF2446B3
Substance obtained.
第1図はSF2446A2物質(2’Oμg/+1)の
紫外部及び可視部吸収スペクトルを示し、実線(−)は
メタノール溶液中、破線(−−−−−−−)は0.1規
定塩酸−メタノール溶液中、−点鎖線(−−−)は0.
1規定水酸化ナトリウム−メタノール溶液中を示す。
第2図はSF2446A3物質(20Hg7xfl)の
紫外部及び可視部吸収スベクレレを示し、実線(−)は
メタノール溶液中、破線< −−−−−−−)は0.1
規定塩酸−メタノール溶液中、−点鎖線(−−−)は0
.1規定水酸化ナトリウム−メタノール溶液中を示す。
第3図はSF2446B1物質(20Hg/xl)の紫
外部及び可視部吸収スペクトルを示し、実線(−)はメ
タノール溶液中、破線(−−−−−−−)は0.1規定
塩酸−メタノール溶液中、−点鎖線(−−−)は0.1
規定水酸化ナトリウム−メタノール溶液中を示す。
第4図はSF2446B2物質(20μg)社)の紫外
部及び可視部吸収スペクトルを示し、実線(−)はメタ
ノール溶液中、破線(−−−−−−・)は0.1規定塩
酸−メタノール溶液中、−点鎖線(−−−)は0.1規
定水酸化ナトリウム−メタノール溶液中を示す。
第5図はSF2446B3物質(20μg/1Ip)の
紫外部及び可視部吸収スペクトルを示し、実線(−)は
メタ/−ル溶液中、破線(−−−−−−−)は0.1規
定塩酸−メタノール溶液中、−点鎖線(−−−)は0.
1規定水酸化ナトリウム−メタノール溶液中を示す。
第6図はSF2446A2物質の臭化カリウム錠での赤
外部吸収スペクトルを示す。
第7図はSF2446^3物質の臭化カリウム錠での赤
外部吸収スペクトルを示す。
第8図はSF2446B1物質の臭化カリウム錠での赤
外部吸収スペクトルを示す。
第9図はSF2446B2物質の臭化カリウム錠での赤
外部吸収スペクトルを示す。
第10図はSF2446B3物質の臭化カリウム錠での
赤外部吸収スペクトルを示す。
第11図はSF2446八2の重クロロホルム溶液中、
TMSを基準物質として測定した400MHz1HNM
Rスペクトルを示す。
第12図はSF2446A3の重クロロホルム溶液中、
TMSを基準物質として測定した400MHz1HNM
Rスペクトルを示す。
第13図はSF2446B1の重クロロホルム溶液中、
TMSを基準物質として測定した400MHz1HNM
Rスペクトルを示す。
第14図はSF2446B2の重クロロホルム溶液中、
TMSを基準物質として測定した400MHz1HNM
Rスペクトルを示す。
第15図はSF2446B3の重クロロホルム溶液中、
TMSを基準物質として測定した400MHz1HNM
Rスペクトルを示す。
第16図はSF2446A2の重クロロホルム溶液中、
TMSを基準物質として測定した100MHz”CNM
Rスペクトルを示す。
第17図はSF2446A3の重クロロホルム溶液中、
TMSを基準物質として測定した100MHz”CNM
Rスペクレレを示す。
第18図はSF2446B1の重クロロホルム溶液中、
TMSを基準物質として測定した100MHz”CNM
R又ベクトルを示す。
第19図はSF2446B2の重クロロホルム溶液中、
TMSを基準物質として測定した100MHz13CN
MRスペクトルを示す。
第20図はSF2446B3の重クロロホルム溶液中、
TMSを基準物質として測定した100MHz13CN
MRスペクトルを示す。Figure 1 shows the ultraviolet and visible absorption spectra of SF2446A2 substance (2'Oμg/+1), where the solid line (-) is in methanol solution and the broken line (----) is in 0.1N hydrochloric acid. In the methanol solution, the - dotted chain line (---) indicates 0.
Shown in 1N sodium hydroxide-methanol solution. Figure 2 shows the ultraviolet and visible absorption levels of SF2446A3 substance (20Hg7xfl), where the solid line (-) is in methanol solution and the broken line < --------- is 0.1
In normal hydrochloric acid-methanol solution, - dotted line (---) is 0
.. Shown in 1N sodium hydroxide-methanol solution. Figure 3 shows the ultraviolet and visible absorption spectra of SF2446B1 substance (20Hg/xl), where the solid line (-) is in methanol solution and the broken line (-------) is in 0.1N hydrochloric acid-methanol solution. In the middle, the -dotted chain line (---) is 0.1
Shown in normal sodium hydroxide-methanol solution. Figure 4 shows the ultraviolet and visible absorption spectra of SF2446B2 substance (20 μg) (Substance 2446B2 (20 μg)), where the solid line (-) is in methanol solution and the broken line (-----) is in 0.1N hydrochloric acid-methanol solution. Inside, the dashed line (---) indicates the 0.1N sodium hydroxide-methanol solution. Figure 5 shows the ultraviolet and visible absorption spectra of SF2446B3 substance (20μg/1Ip), where the solid line (-) is in methanol solution and the broken line (----) is in 0.1N hydrochloric acid. - In the methanol solution, - the dashed line (---) is 0.
Shown in 1N sodium hydroxide-methanol solution. FIG. 6 shows the infrared absorption spectrum of SF2446A2 substance in potassium bromide tablets. FIG. 7 shows the infrared absorption spectrum of SF2446^3 substance in potassium bromide tablets. FIG. 8 shows the infrared absorption spectrum of SF2446B1 substance in potassium bromide tablets. FIG. 9 shows the infrared absorption spectrum of SF2446B2 substance in potassium bromide tablets. FIG. 10 shows the infrared absorption spectrum of SF2446B3 substance in potassium bromide tablets. Figure 11 shows SF244682 in deuterated chloroform solution;
400MHz1HNM measured using TMS as a reference material
The R spectrum is shown. Figure 12 shows SF2446A3 in deuterated chloroform solution,
400MHz1HNM measured using TMS as a reference material
The R spectrum is shown. Figure 13 shows SF2446B1 in deuterated chloroform solution,
400MHz1HNM measured using TMS as a reference material
The R spectrum is shown. Figure 14 shows SF2446B2 in deuterated chloroform solution,
400MHz1HNM measured using TMS as a reference material
The R spectrum is shown. Figure 15 shows SF2446B3 in deuterated chloroform solution,
400MHz1HNM measured using TMS as a reference material
The R spectrum is shown. Figure 16 shows SF2446A2 in deuterated chloroform solution,
100MHz”CNM measured using TMS as a reference material
The R spectrum is shown. Figure 17 shows SF2446A3 in deuterated chloroform solution,
100MHz”CNM measured using TMS as a reference material
R specklere is shown. Figure 18 shows SF2446B1 in deuterated chloroform solution,
100MHz”CNM measured using TMS as a reference material
R also indicates a vector. Figure 19 shows SF2446B2 in deuterated chloroform solution,
100MHz13CN measured using TMS as a reference material
An MR spectrum is shown. Figure 20 shows SF2446B3 in deuterated chloroform solution,
100MHz13CN measured using TMS as a reference material
An MR spectrum is shown.
Claims (1)
、A3、B1、B2物質およびそれらの塩; (a)SF2446A2物質 (1)色及び形状:赤褐色粉末 (2)元素分析値:C58.10%、H5.26%、N
1.90% (3)分子式:C_3_4H_3_5NO_1_5 (4)マススペクトル(FD−MS):_m_/_z6
97(M^+) (5)融点:180−184℃(分解) (6)紫外部及び可視部吸収スペクトル:第1図 (7)赤外部吸収スペクトル:第6図 (8)^1HNMRスペクトル(400MHz、CDC
l_3):第11図 (9)^1^3CNMRスペクトル(100MHz、C
DCl_3):第16図 (10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。 (11)溶解性:メタノール、クロロホルム、酢酸エチ
ル、アセトンに溶け、 水に溶けない。 (12)薄層クロマトグラフィ一: 担体シリカゲルプレート(メルク社製) ▲数式、化学式、表等があります▼ (13)塩基性、酸性、中性の区別:弱酸性物質(b)
SF2446A3物質 (1)色及び形状:赤褐色粉末 (2)元素分析値:C59.04%、H4.12%、N
2.53% (3)分子式:C_2_6H_2_1NO_1_1 (4)マススペクトル(FD−MS):_m_/_z5
23(M^+) (5)融点:>220℃ (6)紫外部及び可視部吸収スペクトル:第2図 (7)赤外部吸収スペクトル:第7図 (8)^1HNMRスペクトル(400MHz、CDC
l_3):第12図 (9)^1^3CNMRスペクトル(100MHz、C
DCl_3):第17図 (10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。 (11)溶解性:メタノール、クロロホルム、酢酸エチ
ル、アセトンに溶け、 水に溶けない。 (12)薄層クロマトグラフィー: 担体シリカゲルプレート(メルク社製) ▲数式、化学式、表等があります▼ (13)塩基性、酸性、中性の区別:弱酸性物質(c)
SF2446B1物質 (1)色及び形状:赤褐色粉末 (2)元素分析値:C59.72%、H5.35%、N
2.21% (3)分子式:C_3_4H_3_5NO_1_4 (4)マススペクトル(FD−MS):_m_/_z6
82(MH^+) (5)融点:1SS−192℃(分解) (6)紫外部及び可視部吸収スペクトル:第3図 (7)赤外部吸収スペクトル:第8図 (8)^1HNMRスペクトル(400MHz、CDC
l_3):第13図 (9)^1^3CNMRスペクトル(100MHz、C
DCl_3):第18図 (10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。 (11)溶解性:メタノール、クロロホルム、酢酸エチ
ル、アセトンに溶け、 水に溶けない。 (12)薄層クロマトグラフィー: 担体シリカゲルプレート(メルク社製) ▲数式、化学式、表等があります▼ (13)塩基性、酸性、中性の区別:弱酸性物質(d)
SF2446B2物質 (1)色及び形状:赤褐色粉末 (2)元素分析値:C59.16%、H5.18%、N
2.05% (3)分子式:C_3_4H_3_5NO_1_4 (4)マススペクトル(FD−MS):_m_/_z6
81(M^+) (5)融点:177−181℃(分解) (6)紫外部及び可視部吸収スペクトル:第4図 (7)赤外部吸収スペクトル:第9図 (8)^1HNMRスペクトル(400MHz、CDC
l_3):第14図 (9)^1^3CNMRスペクトル(100MHz、C
DCl_3):第19図 (10)呈色反応:10%硫酸、モリブデン酸試薬に陽
性である。 (11)溶解性:メタノール、クロロホルム、酢酸エチ
ル、アセトンに溶け、 水に溶けない。 (12)薄層クロマトグラフィー: 担体シリカゲルプレート(メルク社製) ▲数式、化学式、表等があります▼ (13)塩基性、酸性、中性の区別:弱酸性物質(e)
新規抗生物質SF2446B3物質 (1)色及び形状:赤褐色粉末 (2)分子式:C_2_6H_2_1NO_1_0 (3)マススペクトル(FD−MS):_m_/_z5
07(M^+) (4)融点:1S7−192℃ (5)紫外部及び可視部吸収スペクトル:第5図 (6)赤外部吸収スペクトル:第10図 (7)^1HNMRスペクトル(400MHz、CDC
l_3):第15図 (8)^1^3CNMRスペクトル(100MHz、C
DCl_3):第20図 (9)呈色反応:10%硫酸、モリブデン酸試薬に陽性
である。 (10)溶解性:メタノール、クロロホルム、酢酸エチ
ル、アセトンに溶け、 水に溶けない。 (11)薄層クロマトグラフィー: 担体シリカゲルプレート(メルク社製) ▲数式、化学式、表等があります▼ (12)塩基性、酸性、中性の区別:弱酸性物質[Claims] 1. Novel antibiotic SF2446A2 having the following properties
, A3, B1, B2 substances and their salts; (a) SF2446A2 substance (1) Color and shape: reddish brown powder (2) Elemental analysis values: C58.10%, H5.26%, N
1.90% (3) Molecular formula: C_3_4H_3_5NO_1_5 (4) Mass spectrum (FD-MS):_m_/_z6
97 (M^+) (5) Melting point: 180-184°C (decomposed) (6) Ultraviolet and visible absorption spectra: Figure 1 (7) Infrared absorption spectrum: Figure 6 (8)^1H NMR spectrum ( 400MHz, CDC
l_3): Figure 11 (9)^1^3CNMR spectrum (100MHz, C
DCl_3): Figure 16 (10) Color reaction: Positive for 10% sulfuric acid and molybdate reagent. (11) Solubility: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water. (12) Thin layer chromatography: Support silica gel plate (manufactured by Merck & Co.) ▲ Contains mathematical formulas, chemical formulas, tables, etc. ▼ (13) Distinction between basic, acidic, and neutral: Weakly acidic substances (b)
SF2446A3 substance (1) Color and shape: Reddish brown powder (2) Elemental analysis: C59.04%, H4.12%, N
2.53% (3) Molecular formula: C_2_6H_2_1NO_1_1 (4) Mass spectrum (FD-MS):_m_/_z5
23 (M^+) (5) Melting point: >220°C (6) Ultraviolet and visible absorption spectra: Figure 2 (7) Infrared absorption spectrum: Figure 7 (8)^1H NMR spectrum (400MHz, CDC
l_3): Figure 12 (9)^1^3CNMR spectrum (100MHz, C
DCl_3): Figure 17 (10) Color reaction: Positive for 10% sulfuric acid and molybdate reagent. (11) Solubility: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water. (12) Thin layer chromatography: Carrier silica gel plate (manufactured by Merck & Co.) ▲ Contains mathematical formulas, chemical formulas, tables, etc. ▼ (13) Distinction between basic, acidic, and neutral: Weakly acidic substances (c)
SF2446B1 Substance (1) Color and shape: Reddish brown powder (2) Elemental analysis: C59.72%, H5.35%, N
2.21% (3) Molecular formula: C_3_4H_3_5NO_1_4 (4) Mass spectrum (FD-MS):_m_/_z6
82 (MH^+) (5) Melting point: 1SS-192°C (decomposition) (6) Ultraviolet and visible absorption spectra: Figure 3 (7) Infrared absorption spectrum: Figure 8 (8)^1H NMR spectrum ( 400MHz, CDC
l_3): Figure 13 (9)^1^3CNMR spectrum (100MHz, C
DCl_3): Figure 18 (10) Color reaction: Positive for 10% sulfuric acid and molybdate reagent. (11) Solubility: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water. (12) Thin layer chromatography: Carrier silica gel plate (manufactured by Merck & Co.) ▲ Contains mathematical formulas, chemical formulas, tables, etc. ▼ (13) Distinction between basic, acidic, and neutral: Weakly acidic substances (d)
SF2446B2 substance (1) Color and shape: Reddish brown powder (2) Elemental analysis: C59.16%, H5.18%, N
2.05% (3) Molecular formula: C_3_4H_3_5NO_1_4 (4) Mass spectrum (FD-MS):_m_/_z6
81 (M^+) (5) Melting point: 177-181°C (decomposed) (6) Ultraviolet and visible absorption spectra: Figure 4 (7) Infrared absorption spectrum: Figure 9 (8)^1H NMR spectrum ( 400MHz, CDC
l_3): Figure 14 (9)^1^3CNMR spectrum (100MHz, C
DCl_3): Figure 19 (10) Color reaction: Positive for 10% sulfuric acid and molybdate reagent. (11) Solubility: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water. (12) Thin layer chromatography: Carrier silica gel plate (manufactured by Merck & Co.) ▲ Contains mathematical formulas, chemical formulas, tables, etc. ▼ (13) Distinction between basic, acidic, and neutral: Weakly acidic substances (e)
New antibiotic SF2446B3 substance (1) Color and shape: Reddish brown powder (2) Molecular formula: C_2_6H_2_1NO_1_0 (3) Mass spectrum (FD-MS):_m_/_z5
07 (M^+) (4) Melting point: 1S7-192°C (5) Ultraviolet and visible absorption spectra: Figure 5 (6) Infrared absorption spectrum: Figure 10 (7) ^1H NMR spectrum (400MHz, CDC
l_3): Figure 15 (8)^1^3CNMR spectrum (100MHz, C
DCl_3): Figure 20 (9) Color reaction: Positive for 10% sulfuric acid and molybdate reagent. (10) Solubility: Soluble in methanol, chloroform, ethyl acetate, acetone, insoluble in water. (11) Thin layer chromatography: Carrier silica gel plate (manufactured by Merck) ▲ Contains mathematical formulas, chemical formulas, tables, etc. ▼ (12) Distinction between basic, acidic, and neutral: Weakly acidic substances
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25386087A JPH0196189A (en) | 1987-10-09 | 1987-10-09 | Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25386087A JPH0196189A (en) | 1987-10-09 | 1987-10-09 | Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0196189A true JPH0196189A (en) | 1989-04-14 |
JPH05380B2 JPH05380B2 (en) | 1993-01-05 |
Family
ID=17257137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25386087A Granted JPH0196189A (en) | 1987-10-09 | 1987-10-09 | Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0196189A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2593112A2 (en) * | 2010-07-09 | 2013-05-22 | Albany Molecular Research, Inc. | Novel antibacterial compounds, methods of making them, and uses thereof |
WO2017093114A1 (en) | 2015-12-02 | 2017-06-08 | Fondazione Istituto Insubrico Di Ricerca Per La Vita | Antibiotic fiirv 104/18 complex and the isolated individual factors thereof |
-
1987
- 1987-10-09 JP JP25386087A patent/JPH0196189A/en active Granted
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2593112A2 (en) * | 2010-07-09 | 2013-05-22 | Albany Molecular Research, Inc. | Novel antibacterial compounds, methods of making them, and uses thereof |
US8754054B2 (en) | 2010-07-09 | 2014-06-17 | Albany Molecular Research, Inc. | Antibacterial compounds, methods of making them, and uses thereof |
EP2593112A4 (en) * | 2010-07-09 | 2014-07-23 | Albany Molecular Res Inc | Novel antibacterial compounds, methods of making them, and uses thereof |
WO2017093114A1 (en) | 2015-12-02 | 2017-06-08 | Fondazione Istituto Insubrico Di Ricerca Per La Vita | Antibiotic fiirv 104/18 complex and the isolated individual factors thereof |
Also Published As
Publication number | Publication date |
---|---|
JPH05380B2 (en) | 1993-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61148189A (en) | Cl-1577d and cl-1577e antibiotic/antitumoral compounds and manufacture | |
JPH0196189A (en) | Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance | |
JP2695225B2 (en) | New substance UCT-1003 | |
JPH0740950B2 (en) | Microbial production of nicotianamine | |
JPS63154695A (en) | Novel antibiotic substance sf2446 and production thereof | |
JPH0912550A (en) | 2,2'-bipyridine derivative, its production and antineoplastic agent containing the same | |
JPH0625095B2 (en) | Antibiotic SF-2415 substance and its production method | |
JP3100785B2 (en) | Novel avermectin derivative, method for producing the same and microorganism producing the same | |
JPS63188695A (en) | Erythromycin b derivative and production thereof | |
JPS6219599A (en) | Novel macrolide antibiotic m119 | |
JPH09157266A (en) | New antibiotic epoxynomicin a and b and their production | |
JP2594085B2 (en) | SF2575, a new antitumor antibiotic, and method for producing the same | |
JPS63162697A (en) | Novel antibiotic substance sf-2415a3 and sf-2415b3 and production thereof | |
JPH0525160A (en) | Antimycotic substance mer-wf 5027-11 | |
JPS597314B2 (en) | Manufacturing method for new antibiotics | |
JPH01139590A (en) | Novel antibiotic substances sf2582a and b and production thereof | |
JPH08208644A (en) | New antibiotic substance cremimycin, its production and use | |
JPS60155189A (en) | Antibiotic substance al-r6-4 and its preparation | |
JPH01265890A (en) | Substance sf2582 of novel antibiotic and production thereof | |
JPS6255090A (en) | Novel antibiotic substance sf-2392 and production thereof | |
JPH0343266B2 (en) | ||
JPS5932120B2 (en) | Method for producing 9-β-D arabinofuranosyl adenine | |
JPS6230735A (en) | Novel antibiotic substance sf-2418 and production thereof | |
JPH0633301B2 (en) | Novel antibiotics SF2695A substance and SF2695B substance and method for producing the same | |
JPH0662660B2 (en) | Novel antibiotic PF1042 substance and its production method |